Biologics Drug Delivery & Beyond

Conference Brochure

Add Event To Calendar

Save the event dates in your Outlook calendar

Customer Service

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200
------------------------------------
Need Technical Assistance With this Website?
Send an email to IIR's Web Department

Home

Home

Delivering Over 15 Case Studies Offering Solutions for Successful Macromolecule Development for Faster Commercialization Brought to you by the creators of Drug Delivery Partnerships

Welcome to the Delivery of Biologics & Beyond event, featuring an excellent speaking faculty of senior-level scientists and technology/product developers to share new advances and address your most pressing challenges in formulating and delivering biologics and nuclear acids. The development of macromolecules such as proteins, peptides, oligonucleotides, RNA and DNA is widely recognized as the future of the Pharmaceutical and Biotech industry. While many formulation strategies have been developed and refined throughout the past few years, the industry still faces additional challenges in developing needle-free delivery of biologics. Join us to hear the latest case studies, discover the drug delivery technology advances for biologics, and see what technologies hold the most promise for needle-free delivery of biologics.

Ground-Breaking Case Studies & Presentations
  • Choosing the right delivery system for your unique product formulation
  • Development and Advances in Targeted Drug Delivery for Biologics
  • Formulation Strategies for use in Injectable and Inhalable Devices
  • Challenges to Delivering High Protein Drug Content in Small Volume Dose 
  • PEG-Like Protein Sequences for Half-Life Extension of Protein Therapeutics
  • Enhancing the Potency of Nucleic Acid-Based Drugs with Electroporation
  • Develop Novel Methods for Combined Imaging and Delivery of siRNA to Disease-Relevant Targets     
  • Mimicking Endogenous Peptide Secretion with Inhaled Dry Powder Formulations
  • Delivery of Synthetic Oligonucleotides
  • Injecting Biological Drugs and Vaccines in a Solid Dosage Form
Resources
Biologics Drug Delivery & Beyond: Join our LinkedIn Group

Presentations

Biologics Drug Delivery & Beyond Presentation: PNT2258: A Novel DNAi for the Treatment of CancerPNT2258: A Novel DNAi for the Treatment of Cancer
Biologics Drug Delivery & Beyond Presentation: Vaxfectin® as an Adjuvant for DNA-based Vaccines Vaxfectin® as an Adjuvant for DNA-based Vaccines
Advances in Vaccine DeliveryAdvances in Vaccine Delivery

 

Participating Companies

Dicerna | Pfizer | Aradigm | Pfizer Global Biologics | Ichor Medical Systems | Genzyme
Stryker Biotech | Mannkind Corporation | Massachusetts General Hospital | Glide Pharmaceuticals
Pronai | Amgen | Amunix | Stryker Biotech | Rxi Pharmaceuticals

Home    Register    Brochure    Send to a Colleague
© 2009 IIR USA, LTD. All Rights Reserved.